Identity
- Security key
- 13251
- Ticker
- CDXS
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2010-04-22
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CDXS
Detail
Enriched 2026-08-14 20:47
- Market cap
- $175,209,224
- Shares outstanding (class)
- 90,896,567
- Shares outstanding (weighted)
- 109,505,765
- SIC
- 2860 INDUSTRIAL ORGANIC CHEMICALS
- Employees
- 146
- Location
- REDWOOD CITY, CA
- Homepage
- https://www.codexis.com
- Description
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.